Literature DB >> 6237121

Spinal fluid lymphocytes responsive to autologous and allogeneic cells in multiple sclerosis and control individuals.

G Birnbaum, L Kotilinek, M Schwartz, M Sternad.   

Abstract

Spinal fluid lymphocytes from multiple sclerosis (MS) patients and controls were stimulated with either autologous non-T cells or with allogeneic non-T cells followed by stimulation with autologous non-T lymphocytes. Cells responding to these stimuli were cloned and their proliferative responses to autologous and allogeneic MS and normal non-T cells were measured. Large numbers of clones with specific patterns of reaction to both autologous and allogeneic cells were obtained from lymphocytes in MS cerebrospinal fluid (CSF), but only occasionally from cells in control CSF. Patterns of responses among clones from a particular CSF were similar and often identical, which suggested that cells in MS CSF were relatively restricted in their specificities. Surface antigen phenotyping of the clones showed them to be predominantly OKT4+, with 13% OKT8+ and 11% OKT4+8+. Peripheral T cells that were stimulated and cultured in parallel with CSF cells were different in that they usually did not give rise to as many clones nor were their patterns of response similar. Many CSF clones were heteroclitic, that is they responded to particular allogeneic cells but not autologous cells. Lymphocytes in MS CSF thus appear to represent a selected population of cells with a high frequency of responsiveness to autologous and allogeneic antigens. Such responses may be evidence for immune regulation within the central nervous system or could represent responses to altered-self antigens.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6237121      PMCID: PMC425298          DOI: 10.1172/JCI111541

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  Cerebrospinal fluid T and B lymphocyte kinetics related to exacerbations of multiple sclerosis.

Authors:  J C Allen; W Sheremata; J B Cosgrove; K Osterland; M Shea
Journal:  Neurology       Date:  1976-06       Impact factor: 9.910

2.  Immunologic characterization of cerebrospinal fluid lymphocytes: preliminary report.

Authors:  A I Levinson; R P Lisak; B Zweiman
Journal:  Neurology       Date:  1976-07       Impact factor: 9.910

3.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

4.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

5.  Immunoglobulins in multiple sclerosis and infections of the nervous system.

Authors:  H Link; R Müller
Journal:  Arch Neurol       Date:  1971-10

6.  Subacute sclerosing panencephalitis: isolation of suppressed measles virus from lymph node biopsies.

Authors:  L Horta-Barbosa; R Hamilton; B Wittig; D A Fuccillo; J L Sever; M L Vernon
Journal:  Science       Date:  1971-08-27       Impact factor: 47.728

7.  Cerebrospinal fluid lymphocytes from patients with multiple sclerosis and aseptic meningo-encephalitis respond in mixed lymphocyte culture.

Authors:  S Kam-Hansen; R Andersson; H Link
Journal:  J Neuroimmunol       Date:  1983-08       Impact factor: 3.478

8.  Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Part 1. Association between amount of prostaglandin produced, natural killer, and endogenous interferon.

Authors:  J E Merrill; R H Gerner; L W Myers; G W Ellison
Journal:  J Neuroimmunol       Date:  1983-06       Impact factor: 3.478

9.  Specificity of T cell clones for antigen and autologous major histocompatibility complex products determines specificity for foreign major histocompatibility complex products.

Authors:  S R Abromson-Leeman; H Cantor
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

10.  Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants.

Authors:  J S Gaston; A B Rickinson; M A Epstein
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

View more
  2 in total

1.  Defective autologous mixed lymphocyte reactivity in multiple sclerosis.

Authors:  R L Hirsch
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

2.  Human oligodendrocytes are susceptible to cytolysis by major histocompatibility complex class I-restricted lymphocytes.

Authors:  T C Ruijs; M S Freedman; Y G Grenier; A Olivier; J P Antel
Journal:  J Neuroimmunol       Date:  1990-05       Impact factor: 3.478

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.